Company attributes
Industry
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
Apic Bio, Inc.
Legal classification
Date Incorporated
2017
Spun Out From
Number of Employees (Ranges)
11 – 50
Email Address
info@apic-bio.com0
apic@argotpartners.com0
patientservices@apic-bio.com0
Full Address
35 CAMBRIDGEPORT DRIVE, SUITE 350, CAMBRIDGE, MA, 02140-23250
CIK Number
Investors
Founded Date
2017
0Total Funding Amount (USD)
70,739,760
Latest Funding Round Date
December 29, 2021
Competitors
CFO
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Apic Bio is a developer of a gene therapy proprietary platform designed for patients with genetic diseases. The company's platform offers APB-101 which targets the liver by way of an AAV delivered Dual Function Vector, enabling doctors to treat rare, devastating neurological and liver diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
